← Open Payments lookup

EDWARD ARIAS: Open Payments

NPI 1922018993 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,576 in 56 payments from 16 companies in 2025. Trend: 2023 $667 · 2024 $965 · 2025 $1,576

Food & beverage: $1,576
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$457
UCB, Inc.19$299
Vanda Pharmaceuticals Inc.6$138
JAZZ PHARMACEUTICALS INC.1$122
Lundbeck LLC4$112
Exact Sciences Corporation4$107
Amgen Inc.3$58
Lilly USA, LLC3$50
Bayer Healthcare Pharmaceuticals Inc.2$47
SK Life Science, Inc.1$35

Products named: Fintepla, REXULTI, HETLIOZ, EPIDIOLEX, INGREZZA, The Cologuard Plus Collection Kit, OTEZLA, MOUNJARO.

Industry payments across CA — which companies pay providers there.